INVITRO EFFECT OF ACTINOMYCIN-D ON HUMAN NEUTROPHIL FUNCTION

被引:7
作者
CHANG, FY
SHAIO, MF
机构
[1] NATL DEF MED CTR,DEPT PARASITOL & TROP MED,TAIPEI,TAIWAN
[2] NATL DEF MED CTR,GRAD INST MED SCI,TAIPEI,TAIWAN
关键词
D O I
10.1111/j.1348-0421.1990.tb01012.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of actinomycin D (ACT-D) on human neutrophil chemo-taxis, chemiluminescence (CL), superoxide (O2−) production, phagocytic uptake, and intracellular bacterial killing has been examined. The viability of the ACT-D-treated neutrophils was 98% even at a concentration of 10 μg/ml for 4 hr. Using fMLP as the chemotactic factor, depressed chemotaxis was demonstrated following ACT-D (1—10 μg/ml) pretreatment of neutrophils as compared with the non-treated controls. Similar ACT-D pretreatment produced the depressed responses in phorbol myristate acetate-induced CL and superoxide production by neutrophils. Moreover, using heat-inactivated human serum as an opsonin for Salmonella enteritidis (NCTC 6676), there was a significant difference in intracellular killing (P<0.01) but no difference in phagocytic uptake between ACT-D-treated and non-treated neutrophils. These studies indicate that ACT-D profoundly impairs both intracellular bacterial killing by human neutrophil through an effect on respiratory burst activity and directed cell migration of human neutrophils. © 1990, Center For Academic Publications Japan. All rights reserved.
引用
收藏
页码:311 / 321
页数:11
相关论文
共 31 条
[1]  
AUSTGULEN R, 1986, CANCER RES, V46, P4566
[2]  
BABIOR BM, 1981, LEUKOCYTE FUNCTION, P1
[3]  
BENJAMIN RS, 1976, CANCER TREAT REP, V60, P289
[4]   INFECTIONS IN CANCER-PATIENTS [J].
BODEY, GP .
CANCER TREATMENT REVIEWS, 1975, 2 (02) :89-+
[5]   KINETIC-STUDIES OF ACTINOMYCIN-D-BINDING TO MONONUCLEOTIDES, OLIGONUCLEOTIDES, AND POLYNUCLEOTIDES [J].
BROWN, SC ;
SHAFER, RH .
BIOCHEMISTRY, 1987, 26 (01) :277-282
[6]   IMPAIRED INVITRO POLYMORPHONUCLEAR FUNCTION SECONDARY TO THE CHEMOTHERAPEUTIC EFFECTS OF VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND ACTINOMYCIN-D [J].
CAIRO, MS ;
MALLETT, C ;
VANDEVEN, C ;
KEMPERT, P ;
BENNETTS, GA ;
KATZ, J .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :798-804
[7]   ORIGIN OF CHEMILUMINESCENCE OF PHAGOCYTOSING GRANULOCYTES [J].
CHESON, BD ;
CHRISTENSEN, RL ;
SPERLING, R ;
KOHLER, BE ;
BABIOR, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (04) :789-796
[8]  
COLLOTA F, 1986, IMMUNOLOGY, V57, P249
[9]  
CRIST WM, 1985, CANCER, V56, P2125, DOI 10.1002/1097-0142(19851015)56:8<2125::AID-CNCR2820560841>3.0.CO
[10]  
2-D